Post date May 17, 2023 Experience Forbion European Acquisition combination with enGene We are advising Forbion European Acquisition on its de-SPAC transaction
Post date May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction
Post date May 3, 2023 Experience Invacare chapter 11 plan confirmed We advised the prepetition term loan agent and escrow agent on the transaction
Post date March 7, 2023 Experience Atairos acquisition of LifeLabs Learning We are advising Atairos on the transaction
Post date March 3, 2023 Experience European Biotech Acquisition $220 million combination with Oculis We advised European Biotech Acquisition on its de-SPAC transaction
Post date January 19, 2023 Experience Sun Pharmaceutical acquisition of Concert Pharmaceuticals We advised Sun Pharmaceutical on the transaction
Post date December 14, 2022 Experience Priveterra Acquisition initial business combination with AEON Biopharma We are advising Priveterra on the transaction
Post date November 15, 2022 Experience Metalmark Capital up to $50 million investment in Morgenesis We advised Metalmark on the transaction
Post date November 9, 2022 Experience Molded Devices acquisition of GlobalMed and Schauenburg-Truplast We advised Molded Devices on the acquisition and the related financing arrangements
Post date November 1, 2022 Experience Johnson & Johnson $16.6 billion acquisition of Abiomed We are advising J.P. Morgan Securities as financial adviser to Johnson & Johnson